ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 683517 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 683517; 2) Community: the network communities that were significantly associated with the response to NSC 683517; 3) Molecule: the relationships between components within communities and NSC 683517; 4) MDR: the compounds that were significantly associated with the NSC 683517.

NSC Compound Enrichment Correlation
NSC 732832 1-{2-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrol ylamino)phenylcarboxamido]ethyl}-3,4-dimethoxybenzene 0.0297837393005855 0.14850294
NSC 100880 Camptothecin 0.0297837393005856 0.041385845
NSC 129790 Null 0.0297837393005856 0.083040176
NSC 13151 Null 0.0297837393005856 0.22219696
NSC 144126 Null 0.0297837393005856 0.43551284
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0297837393005856 0.091771467
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0297837393005856 0.06935018
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0297837393005856 0.48966451
NSC 619030 Analog of CC-1065 0.0297837393005856 0.3658261
NSC 63984 Cordycepin 0.0297837393005856 0.032963714
Total:44  Current:27    [First] [Prev] [Next] [Last]